Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-11.05 Insider Own0.40% Shs Outstand154.51M Perf Week4.93%
Market Cap11.19B Forward P/E15.79 EPS next Y4.59 Insider Trans10.16% Shs Float150.85M Perf Month8.76%
Income-1296.20M PEG- EPS next Q1.10 Inst Own- Short Float10.08% Perf Quarter13.11%
Sales2.50B P/S4.47 EPS this Y21.20% Inst Trans4.25% Short Ratio6.77 Perf Half Y2.58%
Book/sh16.25 P/B4.46 EPS next Y8.54% ROA-15.80% Target Price78.39 Perf Year8.12%
Cash/sh4.62 P/C15.67 EPS next 5Y6.02% ROE-65.70% 52W Range53.62 - 82.16 Perf YTD7.34%
Dividend- P/FCF69.88 EPS past 5Y-33.80% ROI-8.50% 52W High-11.87% Beta1.18
Dividend %- Quick Ratio1.10 Sales past 5Y15.70% Gross Margin54.70% 52W Low35.04% ATR1.90
Employees3371 Current Ratio1.30 Sales Q/Q15.50% Oper. Margin19.40% RSI (14)64.91 Volatility2.52% 2.83%
OptionableYes Debt/Eq1.76 EPS Q/Q-456.50% Profit Margin-57.60% Rel Volume0.86 Prev Close72.22
ShortableYes LT Debt/Eq1.69 EarningsNov 05 BMO Payout- Avg Volume2.25M Price72.41
Recom2.10 SMA205.51% SMA508.01% SMA2007.07% Volume1,924,987 Change0.26%
Sep-02-14Initiated RBC Capital Mkts Outperform $80
Aug-01-14Reiterated Stifel Buy $75 → $84
Jun-27-14Initiated Canaccord Genuity Buy $83
Apr-30-14Initiated National Alliance Securities Buy $76
Mar-04-14Reiterated FBR Capital Mkt Perform $52 → $82
Mar-03-14Reiterated UBS Buy $75 → $90
Nov-06-13Upgrade Needham Underperform → Hold
Nov-06-13Reiterated Stifel Buy $40 → $60
Oct-30-13Initiated FBR Capital Mkt Perform $40
Sep-20-13Reiterated UBS Buy $43 → $50
Jun-21-13Resumed Oppenheimer Perform
Jun-06-13Reiterated UBS Buy $39 → $41
Jun-06-13Reiterated Stifel Buy $36 → $40
Jun-06-13Downgrade Cantor Fitzgerald Hold → Sell $36 → $30
May-13-13Reiterated Stifel Buy $42 → $36
May-08-13Reiterated RBC Capital Mkts Underperform $28 → $29
Apr-17-13Reiterated Stifel Buy $38 → $42
Apr-10-13Downgrade Standpoint Research Buy → Hold
Jan-31-13Reiterated Cantor Fitzgerald Hold $26 → $34
Jan-31-13Downgrade Oppenheimer Outperform → Perform
Nov-24-14 07:00AM  Endo Acquires Rights to Natesto Testosterone Nasal Gel PR Newswire
07:00AM  Endo Acquires Rights to Natesto Testosterone Nasal Gel CNW Group
Nov-20-14 09:57AM  U.S. court denies Ranbaxy's bid to block launch of rival generics Reuters
07:30AM  Endo Announces Launch of Generic Version of Valcyte® PR Newswire
07:30AM  Endo Announces Launch of Generic Version of Valcyte® CNW Group
Nov-19-14 07:30AM  Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals PR Newswire
Nov-18-14 01:04PM  ENDO INTERNATIONAL PLC Financials EDGAR Online Financials
10:01AM  Endo International (ENDP) Strong On High Relative Volume Today at TheStreet
Nov-10-14 05:10PM  ENDO INTERNATIONAL PLC Files SEC form 10-Q, Quarterly Report EDGAR Online
09:54AM  Dr. Reddy's Laboratories: The Bridge to 2016 at Barrons.com
08:00AM  Endo Receives Final Approval for Generic Version of Valcyte® PR Newswire
05:38AM  La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% Zacks
Nov-07-14 05:44AM  Dr Reddy's gets FDA approval for Roche drug generic; shares at record high Reuters
Nov-06-14 11:26PM  Dr Reddy's, Endo get FDA approval to launch generic Valcyte Reuters
08:30AM  Endo International Beats on Q3 Earnings & Sales, View Up Zacks
Nov-05-14 04:29PM  New balance of power on Capitol Hillbut no change in stock prices Yahoo Finance Blogs
12:28PM  Endo raises 2014 outlook again, Q3 profit beats Street Reuters
10:29AM  Endo International (ENDP) Is Today's Water-Logged And Getting Wetter Stock at TheStreet
09:00AM  Endo International PLC Earnings Call scheduled for 9:00 am ET today CCBN
08:46AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
07:22AM  Endo profit beats estimates on strong generic drug sales Reuters
07:07AM  Q3 2014 Endo International PLC Earnings Release - Before Market Open CCBN
07:00AM  Endo Reports Third Quarter Financial Results PR Newswire
Nov-04-14 11:50AM  Zoetis Q3 Earnings Beat Driven by Higher Livestock Sales Zacks
Oct-31-14 02:08PM  Contrarian fund manager's top 3 stock picks at CNBC
12:07PM  Contrarian picks: UAL, LE & ENDP CNBC
Oct-29-14 11:14AM  3 Health Care Picks To Beat Earnings Zacks
08:15AM  Analysts Top 4 Specialty Pharmaceutical Stocks to Buy Before Earnings at 24/7 Wall St.
Oct-20-14 04:00PM  Endo to Announce Third Quarter 2014 Financial Results on November 5, 2014 PR Newswire
Oct-14-14 03:51PM  Sterne Agee Sees Entry Point In Endo International PLC Shares Benzinga
12:01AM  [$$] BioDelivery Sciences May Deliver Less at Barrons.com
Oct-13-14 10:33PM  AUXILIUM PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Auxilium Pharmaceuticals, Inc. PR Newswire
12:42PM  How Will Endo International (ENDP) Stock Be Affected Today by This Analyst Action? at TheStreet
08:00AM  Top Analyst Upgrades and Downgrades: Cliffs, CME, Darden, Endo, J.C. Penney and More at 24/7 Wall St.
Oct-10-14 05:37PM  Inversion Vitriol Vs. Drug Consolidation Investor's Business Daily
04:45PM  Endo to Buy Auxilium for $2.6B, Diversify Portfolio Zacks
02:56PM  UPDATE: Mizuho Securities Downgrades Auxilium Pharmaceuticals Benzinga
06:47AM  The Morning Ledger: Early Inversion Deal Makers Come Back for More at The Wall Street Journal
Oct-09-14 11:58PM  [$$] Tax-Inversion Players Swoop In for Seconds at The Wall Street Journal -5.94%
07:00PM  Endo Buyout Of Auxilium Joins Two Changing Firms at Investor's Business Daily
05:23PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statem EDGAR Online
04:55PM  Dow Suffers Worst One-Day Performance In 2014, Volatility Returns To The Markets Benzinga
02:54PM  Endo bolsters men's healthcare business with Auxilium deal Reuters
01:53PM  How Endo International's $2.6B Deal for Auxilium Benefits Shareholders at TheStreet
09:42AM  [$$] Endo International to Buy Auxilium at The Wall Street Journal
09:32AM  [video] Endo buys Auxilium Pharma at CNBC
09:19AM  Morning Movers: Gap Tumbles on CEO Retirement; Pepsi Pops on Earnings at Barrons.com
09:10AM  Stock Futures Down, Off Lows; Alcoa, United, Auxilium Rise at Investor's Business Daily
08:37AM  Endo Intl to buy Auxilium in deal worth $2.6B AP
08:15AM  US STOCKS-Futures turn lower as global growth concerns weigh Reuters
07:56AM  US STOCKS-Results boost Alcoa, PepsiCo in premarket trading Reuters
07:41AM  Early Movers: PEP, AUXL, ENDP, HLT, MW, RT & more at CNBC
07:02AM  Endo Reaches Deal to Buy Auxilium Pharmaceuticals for $2.6B at TheStreet
06:53AM  Endo to buy Auxilium for $2.6 bln, Auxilium drops QLT deal Reuters
06:48AM  Endo Agrees to Buy Auxilium for $2.6 Billion at Bloomberg
06:30AM  Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion PR Newswire
Oct-06-14 05:15PM  Mylan Surges on Improved Q3 and Full-Year Earnings Outlook Zacks
Oct-03-14 07:58PM  Endo Accused of Conspiring to Delay Generic Version of Opana at Bloomberg
12:11PM  Damages slashed to $34.6 mln in Boston Scientific mesh trial Reuters
Oct-02-14 04:00PM  AbbVie's (ABBV) Humira Gains Yet Another FDA Approval Zacks
Oct-01-14 05:16PM  Endo Finance Co. -- Endo's new mesh litigation accrual is credit negative at Moody's
12:01AM  Endo Said to Pay $400 Million Plus in Vaginal-Mesh Accord at Bloomberg
Sep-30-14 07:35PM  Endo reaches deal to end remaining U.S. lawsuits over mesh Reuters
05:18PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:08PM  Endo Reaches Master Settlement Agreements to Resolve Substantially All Remaining AMS Mesh Litigation Claims PR Newswire
Sep-29-14 04:25PM  Endocyte's TARGET Interim Data Positive for Lung Cancer Zacks
04:20PM  Gilead's HCV Combo Drug Harvoni Secures CHMP Backing Zacks
07:53AM  Radius Health (RDUS) Jumps: Stock Moves 13.9% Higher Zacks
06:50AM  Karyopharm Therapeutics, Inc. (KPTI) Surges: Stock Adds 10.5% Zacks
06:40AM  Cempra (CEMP) Jumps: Stock Up 8.9% in Session Zacks
06:35AM  Cerulean Pharma (CERU) Jumps: Stock Up 9.8% in Session Zacks
Sep-26-14 04:10PM  Alnylam Starts New Study on Cardiac Amyloidosis Patients Zacks
07:31AM  IGI, Laboratories (IG) Jumps: Stock Up 18.1% in Session Zacks
Sep-25-14 05:24PM  BioMarin (BMRN) Faces Threat of Genericization for Kuvan Zacks
04:20PM  Gilead Scores with TAF-based HIV Regimen, Shares Up Zacks
08:00AM  Esperion Therapeutics (ESPR) in Focus: Stock Up 13.4% Zacks
07:54AM  Valeant Pharmaceuticals (VRX) in Focus: Stock Adds 6.9% Zacks
07:31AM  The Zacks Analyst Blog Highlights: Auxilium Pharmaceuticals, QLT, Endo International, Gilead and Regeneron Zacks
Sep-24-14 04:45PM  Galmed's Aramchol Gets Fast-Track Designation in the U.S. Zacks
04:20PM  Emergent BioSolutions Initiates Pivotal Study on BioThrax Zacks
10:06AM  Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA Zacks
07:46AM  ZS Pharma (ZSPH) in Focus: Stock Moves 10.7% Higher Zacks
07:06AM  Salix Pharmaceuticals (SLXP) in Focus: Stock Up 5.8% Zacks
06:39AM  Radius Health (RDUS) in Focus: Stock Surges 17.3% Zacks
Sep-23-14 03:55PM  Supernus Confirms 2014 Outlook, Epilepsy Products in Focus Zacks
02:45PM  Auxilium Pharmaceuticals Favors QLT Deal Over Endo Bid Zacks
Sep-22-14 04:38PM  Auxilium Says Endo Takeover Offer Undervalues Company at Investor's Business Daily
11:20AM  Auxilium says Endo offer undervalues company, but open to talks Reuters
10:27AM  Endo: Buyout offer for Auxilium 'compelling,' provides 'substantial premium' at MarketWatch
09:40AM  4 Stocks Spiking on Big Volume at TheStreet
09:38AM  Endo International Comments On Auxilium Pharmaceutical's Rejection Of Its Acquisition Proposal PR Newswire
07:45AM  Auxilium Pharma rejects Endo's takeover offer AP
07:25AM  Auxilium says Endo's offer "significantly undervalues" company Reuters
Sep-19-14 04:15PM  Spectrum Pharmaceuticals Out-Licenses Products in China Zacks
04:10PM  Bayer to Shed MaterialScience Business, Shares Rise Zacks
08:44AM  Zacks Rank #1 Additions for Friday Zacks
06:59AM  Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% Zacks
Sep-18-14 04:11PM  OncoGenex's Phase III Prostate Cancer Study Fully Enrolled Zacks
08:10AM  Alcobra (ADHD) Worth Watching: Stock Moves 5.1% Higher Zacks
Sep-17-14 06:07PM  Auxilium Mulls Endo Bid; Is $2.2 Billion Enough? at Investor's Business Daily
Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men's and women's health, and prostate health. The company's products also include Aveed, an injectable testosterone preparation to treat male hypogonadism; and BEMA Buprenorphine, a transmucosal form of buprenorphine in Phase III trials for treating moderate to severe chronic pain. It serves pharmacy chains directly; and hospitals, governmental agencies, pharmacies, and physicians through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.